Last Updated May 4, 2010 10:52 AM EDT
Even though the Trovan debacle tarred Pfizer's name -- it may have inspired the book and movie The Constant Gardener -- it's Pfizer that is now emerging as the good guy. Nigerian officials, who earmarked a further $40 million in settlement money for their own healthcare projects, have repeatedly failed to figure out which patients should get the money even though they've had 14 years to do so.
It's a reminder to managers that even when you screw up royally, your company's brand can still retain its dignity as long as you play it straight when fixing the mess. And the Trovan settlement is a mess: About 600 people filed forms demanding compensation even though only 200 people were actually part of the test. In November, Pfizer demanded the DNA of claimants after it emerged that Nigerian officials had lost their list of victims. Various other Nigerian "officials" have been maneuvering for a slice of the payout.
- none of the claimants or applicants whose claim forms are in had met payment requirements.
- none of the $35 million meant for compensation is in the custody of the board.
- the trust fund is arguing that any "outstanding" sum of money should not be returned to Pfizer.
- Pfizer Trovan Case Had 200 Victims But 600 Claim Compensation
- Pfizer Demands DNA of Trovan Victims Who Are Owed Compensation
- List of Pfizer's Trovan Victims Has Been Lost, Nigerian Officials Say
- UPDATED: Pfizer Settles Trovan Case for $75M; Nigerian Kleptocrats to Get $40M
- Claim: LeCarre's "The Constant Gardener" Was Based on Pfizer Trovan Case